| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
The Children’s Medical Research Institute,
Gene Therapy Unit, and
Oncology Research Unit, The New Children’s Hospital, Westmead, Australia
In the process of developing a cancer immunotherapy strategy, we have identified and characterized a novel intracellular reservoir of CD86 protein in peripheral blood monocytes. This observation emerged from studies aimed at using retrovirus vectors to genetically modify tumor cells to express the costimulatory proteins CD80 and CD86. Retrovirus-mediated expression of CD80 and CD86 in T lymphoblastoid CEM cells resulted in an unexpected intracellular focal concentration of both proteins in the genetically modified cells. By extending these studies to an analysis of CD80 and CD86 expression in PBMC, we observed that endogenous CD86 expression in peripheral blood monocytes also involved a similar intracellular focal concentration of the protein. The intracellular concentration of CD86 in monocytes was not due to storage within the Golgi apparatus, and required intact microtubules to retain structural integrity. Furthermore, as the intensity of CD86 fluorescence increased on monocytes as a function of time in vitro, the intracellular focal concentration correspondingly decreased. These results are consistent with antegrade CD86 transport from an intracellular reservoir to the cell surface membrane. In this report, we detail the intracellular and membrane localization studies with tumor cell lines and PBMC, and describe the temporal relationship between intracellular storage and trafficking of CD86 to the cell surface membrane in peripheral blood monocytes. We hypothesize that this intracellular reservoir allows rapid and sustained deployment of an important costimulatory molecule to the monocyte surface membrane during initiation and maturation of the cell-mediated immune response.
This article has been cited by other articles:
|
|
 |
|
  C. M Smyth, S. L Ginn, C. T Deakin, G. J Logan, and I. E Alexander Limiting {gamma}c expression differentially affects signaling via the interleukin (IL)-7 and IL-15 receptors Blood, July 1, 2007; 110(1): 91 - 98. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Smyth, G. Logan, R. Boadle, P. B. Rowe, J. A. Smythe, and I. E. Alexander Differential subcellular localization of CD86 in human PBMC-derived macrophages and DCs, and ultrastructural characterization by immuno-electron microscopy Int. Immunol., February 1, 2005; 17(2): 123 - 132. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Flanagan, J. Middeldorp, and T. Sculley Localization of the Epstein-Barr virus protein LMP 1 to exosomes J. Gen. Virol., July 1, 2003; 84(7): 1871 - 1879. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Hannier, C. Bitegye, and S. Demotz Early Events of TCR Signaling Are Distinct in Human Th1 and Th2 Cells J. Immunol., August 15, 2002; 169(4): 1904 - 1911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Komi and O. Lassila Nonsteroidal anti-estrogens inhibit the functional differentiation of human monocyte-derived dendritic cells Blood, May 1, 2000; 95(9): 2875 - 2882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Smythe, P. D. Fink, G. J. Logan, J. Lees, P. B. Rowe, and I. E. Alexander Human Fibroblasts Transduced with CD80 or CD86 Efficiently trans-Costimulate CD4+ and CD8+ T Lymphocytes in HLA-Restricted Reactions: Implications for Immune Augmentation Cancer Therapy and Autoimmunity J. Immunol., September 15, 1999; 163(6): 3239 - 3249. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
